Mycoplasma in Racing Pigeons (Chronic Respiratory Disease)

Key takeaway: Mycoplasma is the smallest self-replicating prokaryote known, and because it lacks a cell wall it is naturally resistant to beta-lactam antibiotics. Mycoplasma infection in pigeons is commonly called "CRD"; its signs are subtle, its course is prolonged and it can be transmitted vertically, making it the hidden force undermining flock condition and race results. Confirmation and breeder clearance depend on PCR and serological testing.

Mycoplasmosis, commonly called chronic respiratory disease (CRD), is the most common silent respiratory infection in racing pigeons. It quietly erodes a bird's flying stamina and race form, yet because the signs are atypical it is often overlooked. Understanding the biology of Mycoplasma is the first step in science-based control.

Aetiology and molecular mechanism: the smallest bacterium without a cell wall

Mycoplasma belongs to the family Mycoplasmataceae, genus Mycoplasma. It is the smallest self-replicating prokaryote known, with a genome of only about 0.6-1.4 Mb. Its key features:

• No cell wall: it has no peptidoglycan layer, the cell is bounded only by a cell membrane, and its shape is pleomorphic (spherical or filamentous);
• Intrinsic resistance: because there is no cell wall, penicillins, cephalosporins and other beta-lactams are naturally ineffective; it is susceptible to tetracyclines, macrolides and fluoroquinolones;
• Demanding nutrition: in vitro culture requires special media (containing serum and cholesterol); growth is slow and routine culture is difficult.

The mycoplasmas commonly found in infected pigeons include Mycoplasma columborale, M. columbinum and M. columbinasale. This "no cell wall" property directly determines both the choice of medication and the testing strategy.

Routes of transmission and the hidden harm

Transmission route	Explanation
Direct contact	Respiratory secretions of sick or carrier birds spread by contact and aerosol
Vertical transmission	Breeders pass the organism to squabs through the egg
Mixed infection	Frequently concurrent with Newcastle disease, adenovirus and Chlamydia, worsening the disease
Silent carriage	Apparently normal birds that keep shedding — the hardest part of any clearance programme

A single Mycoplasma infection causes only mild signs, but it continuously reduces flying stamina and race form; once a mixed infection develops, the disease becomes markedly more severe.

Typical signs

Site	Presentation
Respiratory tract	Sneezing, head shaking, moist rales, open-mouth breathing
Nasal cavity	Nasal discharge, crusting around the nares
Eyes	Swollen eyelids, tearing, increased secretion
General	Depression, reduced appetite, weight loss

Note: silently carrying pigeons look completely normal yet keep shedding and infecting their loft mates — this is the fundamental reason CRD is so hard to eradicate.

Diagnostic comparison and choice of test

Method	Principle	Application
Bacterial culture	Isolation on special media	Slow and demanding; rarely used for routine diagnosis
Real-time quantitative PCR	Detects Mycoplasma-specific nucleic acid	Confirms infection, supports breeder clearance, quantifies load
Serology (ELISA/agglutination)	Detects antibodies	Flock prevalence surveys, clearance monitoring

Sanshi Bio's racing pigeon pathogen testing uses real-time quantitative PCR to detect Mycoplasma nucleic acid rapidly from pharyngeal or nasal flocked swabs, and can test in parallel with Chlamydia psittaci and Newcastle disease virus to pin down single or mixed infection in one run.

Breeder clearance and practical control

Mycoplasma can be transmitted vertically, so breeder clearance is the core of control:

1. PCR-test the whole flock before the breeding season: sample and screen every breeder;
2. Isolate and treat positive birds: use susceptible antibiotics (tetracyclines/macrolides) under veterinary guidance; avoid blind medication;
3. Retest and only then breed: retest after treatment ends and breed only from birds confirmed negative;
4. Build a negative core population: gradually cull persistent carriers to cut vertical transmission at source;
5. Environmental management: improve ventilation, reduce stocking density and minimise stress to reduce relapse.

Practical tip: dedicated flocked swabs are recommended for pharyngeal or nasal secretions — they release more material than ordinary cotton swabs and give more accurate detection. Blind long-term medication is not only ineffective but also breeds resistant strains.

Key points

1. Mycoplasma is the smallest prokaryote and lacks a cell wall, so it is naturally resistant to beta-lactam antibiotics.
2. CRD signs are subtle and the course prolonged, continuously reducing flying stamina and race form.
3. It readily combines with Chlamydia, Newcastle disease and others, so molecular testing is needed to differentiate.
4. It can be transmitted vertically, making breeder clearance the key to eradication.
5. Test first, then medicate, then retest until negative — a closed management loop.

Quick reference: entities

Pathogen	Chinese name	English name	Classification
NDV	新城疫病毒	Newcastle Disease Virus	Paramyxoviridae
AIV	禽流感病毒	Avian Influenza Virus	Orthomyxoviridae
PiCV	鸽圆环病毒	Pigeon Circovirus	Circoviridae
PHV	鸽疱疹病毒	Pigeon Herpesvirus	Herpesviridae
—	鸽腺病毒	Pigeon Adenovirus	Adenoviridae
—	鸽痘病毒	Pigeon Pox Virus	Poxviridae
C. psittaci	鹦鹉热衣原体	Chlamydia psittaci	Chlamydiaceae
Salmonella	沙门氏菌	Salmonella	Enterobacteriaceae
Mycoplasma	支原体	Mycoplasma	Mycoplasmataceae
T. gallinae	鸽毛滴虫	Trichomonas gallinae	genus Trichomonas
C. albicans	白色念珠菌	Candida albicans	genus Candida

FAQ

How do I tell Mycoplasma and Chlamydia apart?

Both cause respiratory and ocular signs but they are different organisms: Mycoplasma is the smallest bacterium and lacks a cell wall, while Chlamydia is an obligate intracellular parasite. Clinically Mycoplasma mainly gives chronic respiratory disease and nasal discharge, whereas Chlamydia also carries a zoonotic risk. PCR testing for the respective nucleic acid is needed to confirm.

Can chronic respiratory disease be cured?

Correct medication combined with breeder clearance can control and even eliminate Mycoplasma from a flock, but because it relapses easily and persists in the environment, biosecurity management and regular retesting must be maintained.

Can a Mycoplasma infection be cured?

Correct medication combined with breeder clearance controls it effectively, but Mycoplasma relapses readily and requires continuous environmental disinfection and pre-breeding screening to build up a negative population step by step.

What sample is used to test for Mycoplasma?

Dedicated flocked swabs are recommended for pharyngeal or nasal secretions — they release more material than ordinary cotton swabs and give more accurate detection. Ocular secretion samples can also be submitted.

How do I tell whether Mycoplasma is combined with a virus?

Use multiplex PCR or a multi-pathogen panel to screen Newcastle disease, adenovirus, Chlamydia and Mycoplasma in one run, establishing whether the infection is single or mixed and guiding combined medication.

Why is penicillin ineffective against Mycoplasma?

Mycoplasma lacks a cell wall, and penicillins, cephalosporins and other beta-lactam antibiotics kill bacteria precisely by inhibiting cell wall synthesis, so they are naturally ineffective. Tetracyclines, macrolides and similar agents should be used instead.

What does the breeder clearance workflow look like?

PCR-test the whole flock before the breeding season → isolate and treat positive birds → retest and only breed from birds that have turned negative → gradually build a negative core population, cutting vertical transmission at source.

References

• Mycoplasma — Wikipedia
• Chronic respiratory disease — Wikipedia
• Mycoplasma — NCBI Taxonomy

This content is for general information only and is not a diagnosis or treatment recommendation. Consult your veterinarian or the Sanshi Bio technical team for testing and control decisions (WeChat 15612372623 / email [email protected]).